Anti-BPIFA1/SPLUNC1: a new autoantibody prevalent in patients with endstage cystic fibrosis.

Research output: Contribution to journal › Article › Academic › peer-review

Access to Document

@article{40ccc684ce01469c8bf3e3bc9d5e4731,

title = "Anti-BPIFA1/SPLUNC1: a new autoantibody prevalent in patients with endstage cystic fibrosis.",

author = "K. Budding and \{van de Graaf\}, E.A. and T. Hoefnagel and C.E. Hack and H.G. Otten",

year = "2014",

doi = "10.1016/j.jcf.2013.10.005",

language = "English",

volume = "13",

pages = "281--288",

journal = "Journal of Cystic Fibrosis",

issn = "1569-1993",

publisher = "Elsevier",

number = "3",

}

TY - JOUR

T1 - Anti-BPIFA1/SPLUNC1: a new autoantibody prevalent in patients with endstage cystic fibrosis.

AU - Budding, K.

AU - van de Graaf, E.A.

AU - Hoefnagel, T.

AU - Hack, C.E.

AU - Otten, H.G.

PY - 2014

Y1 - 2014

U2 - 10.1016/j.jcf.2013.10.005

DO - 10.1016/j.jcf.2013.10.005

M3 - Article

SN - 1569-1993

VL - 13

SP - 281

EP - 288

JO - Journal of Cystic Fibrosis

JF - Journal of Cystic Fibrosis

IS - 3

ER -